Literature DB >> 18272512

An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit.

Sinéad Kelly1, Jonathan Collins, Maureen Maguire, Catriona Gowing, Michelle Flanagan, Maria Donnelly, Philip G Murphy.   

Abstract

OBJECTIVES: To report an outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit (ITU).
METHODS: An outbreak of colonization with linezolid-resistant S. epidermidis affecting 16 patients in an ITU was investigated using PFGE. Environmental and staff screening was carried out as part of the investigation. Usage of linezolid in the hospital and in the ITU was reviewed. Resistant strains were screened for the presence of the G2576T mutation using PCR-RFLP genotyping. The interventions made to control the outbreak were restriction of linezolid prescription and specific infection control measures, including isolation of colonized patients and increased environmental cleaning.
RESULTS: Linezolid-resistant S. epidermidis strains from the 16 colonized patients were genetically related. The same strain was also cultured from environmental samples in the ITU. An increase in linezolid usage in the hospital and in the ITU occurred in the 6 months prior to the emergence of the resistant strain. Infection control measures and restriction of linezolid prescription controlled the outbreak. All resistant isolates contained the G2576T mutation.
CONCLUSIONS: An outbreak of colonization with linezolid-resistant S. epidermidis occurred in the ITU in our institution. The resistant strain colonized the environment and probably spread from patient to patient. The outbreak was associated with an increase in the linezolid usage in the ITU and in the institution as a whole. Restriction of linezolid usage and infection control measures were introduced to control the outbreak. The emergence of linezolid resistance in S. epidermidis has implications for the use of linezolid as a therapeutic agent.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18272512     DOI: 10.1093/jac/dkn043

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  21 in total

Review 1.  Resistance to linezolid caused by modifications at its binding site on the ribosome.

Authors:  Katherine S Long; Birte Vester
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Pharmacological properties of NAI-603, a well-tolerated semisynthetic derivative of ramoplanin.

Authors:  Daniela Jabes; Cristina Brunati; GianPaolo Candiani; Simona Riva; Gabriella Romanó; Sonia Maffioli; Rosaria Rossi; Matteo Simone; Eleonora Gaspari; Stefano Donadio
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

3.  Staphylococcus epidermidis colonization is highly clonal across US cardiac centers.

Authors:  Rachel J Gordon; Maria Miragaia; Alan D Weinberg; Caroline J Lee; Joana Rolo; Julie C Giacalone; Mark S Slaughter; Pat Pappas; Yoshifumi Naka; Alfred J Tector; Herminia de Lencastre; Franklin D Lowy
Journal:  J Infect Dis       Date:  2012-03-29       Impact factor: 5.226

Review 4.  Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus.

Authors:  M Widerström; J Wiström; A Sjöstedt; T Monsen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

5.  Endemic linezolid-resistant Staphylococcus epidermidis in a critical care unit.

Authors:  M Treviño; L Martínez-Lamas; P A Romero-Jung; J M Giráldez; J Alvarez-Escudero; B J Regueiro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-11-05       Impact factor: 3.267

6.  Polyphyletic emergence of linezolid-resistant staphylococci in the United States.

Authors:  Agnes Wong; Shilpa P Reddy; Davida S Smyth; Maria E Aguero-Rosenfeld; George Sakoulas; D Ashley Robinson
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

7.  Genome sequencing of linezolid-resistant Streptococcus pneumoniae mutants reveals novel mechanisms of resistance.

Authors:  Jie Feng; Andréanne Lupien; Hélène Gingras; Jessica Wasserscheid; Ken Dewar; Danielle Légaré; Marc Ouellette
Journal:  Genome Res       Date:  2009-04-06       Impact factor: 9.043

8.  Detection of new mutations conferring resistance to linezolid in glycopeptide-intermediate susceptibility Staphylococcus hominis subspecies hominis circulating in an intensive care unit.

Authors:  A Sorlozano; J Gutierrez; T Martinez; M E Yuste; J A Perez-Lopez; A Vindel; J Guillen; T Boquete
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-10-30       Impact factor: 3.267

9.  Clinical results of linezolid in arthroplasty and trauma MRSA related infections.

Authors:  James Joel; Simon Matthew Graham; Adam Peckham-Cooper; Nectarios Korres; Helen Tsouchnica; Eleftherios Tsiridis
Journal:  World J Orthop       Date:  2014-04-18

10.  The terminal A domain of the fibrillar accumulation-associated protein (Aap) of Staphylococcus epidermidis mediates adhesion to human corneocytes.

Authors:  Robin L Macintosh; Jane L Brittan; Ritwika Bhattacharya; Howard F Jenkinson; Jeremy Derrick; Mathew Upton; Pauline S Handley
Journal:  J Bacteriol       Date:  2009-09-11       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.